MRNA FUND II LP 4
4 · SIRNA THERAPEUTICS INC · Filed Nov 18, 2003
Insider Transaction Report
Form 4
MRNA FUND II LP
10% Owner
Transactions
- Sale
Common Stock
2003-11-17$6.19/sh−34,652$214,513→ 3,776,658 total(indirect: By Oxford Bioscience Partners IV L.P.) - Sale
Common Stock
2003-11-14$6.29/sh−89$560→ 38,242 total - Sale
Common Stock
2003-11-17$6.19/sh−348$2,154→ 37,894 total - Sale
Common Stock
2003-11-14$6.29/sh−8,911$56,031→ 3,811,310 total(indirect: By Oxford Bioscience Partners IV L.P.)
Footnotes (1)
- [F1]The reporting person shares a common general partner with the partnership that owns the reported securities. The reporting person disclaims beneficial ownership of the reported securities.